SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Activity

8 hedge funds and large institutions have $689K invested in Scinai Immunotherapeutics in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$192K
2
Deutsche Bank
2
Deutsche Bank
Germany
$192K
3
SM
3
Sabby Management
Florida
$139K
4
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$18K
5
VIA
5
Vantage Investment Advisors
Pennsylvania
$136K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
1
Deutsche Bank
Germany
$192K +$188K +263 +4,383%
Renaissance Technologies
2
Renaissance Technologies
New York
$192K +$192K +269 New
SM
3
Sabby Management
Florida
$139K +$139K +194 New
VIA
4
Vantage Investment Advisors
Pennsylvania
$136K +$14.3K +20 +12%
LTFS
5
Ladenburg Thalmann Financial Services
Florida
$18K +$18K +25 New
Wells Fargo
6
Wells Fargo
California
$7K +$2.1K +3 +43%
Morgan Stanley
7
Morgan Stanley
New York
$3K +$1.8K +3 +150%
EWM
8
Edge Wealth Management
New York
$2K – – –